Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. scores highest on Torque (57) and lowest on Price (17). Its PosiPenta is 42.60 out of 100, around the middle of similar companies.
On the Penta Grid this week, Aclaris Therapeutics, Inc. is Grid #448 of 837 in the Healthcare sector in United States, and Grid #2,633 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Aclaris Therapeutics, Inc. | 42.60 | 17 | 37 | 53 | 57 | 49 |
| Shattuck Labs, Inc. | 49.85 | 24 | 41 | 71 | 64 | 49 |
| Phathom Pharmaceuticals, Inc. | 49.53 | 0 | 66 | 30 | 95 | 58 |
| ProKidney Corp. | 35.77 | 0 | 40 | 27 | 57 | 54 |
| MiMedx Group, Inc. | 55.55 | 27 | 84 | 56 | 66 | 46 |
| Evolent Health, Inc. | 43.25 | 35 | 49 | 60 | 24 | 49 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -5.66 |
| P/B ratio | 3.88 |
EEarnings
| Trailing EPS | ₹-54.93 |
| Forward EPS | ₹-74.57 |
NNitro
| Price | 310.67 |
| 52-week high | 625.12 |
| 52-week low | 178.06 |
| Fall from 52-week high | 50.3% |
TTorque
| Return on equity (ROE) | -59.10% |
| Debt-to-equity | 0.01 |
AAnchor
| Beta (price swings) | 0.88 |
| Market cap | ₹4,572 Cr |
| Insider holding | 2.18% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Aclaris Therapeutics, Inc.'s PosiPenta score?
Aclaris Therapeutics, Inc.'s PosiPenta is 42.60 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Aclaris Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Aclaris Therapeutics, Inc. is Grid #448 of 837 in the Healthcare sector in United States, and Grid #2,633 of 4,000 in United States.
Which PosiPenta pillar is strongest for Aclaris Therapeutics, Inc.?
Torque (durability), with a score of 57 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for Aclaris Therapeutics, Inc.?
Price (valuation), with a score of 17 out of 100: much weaker than most similar companies.
Has Aclaris Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 3.17 points, from 39.43 to 42.60.
PositoAI is for research and education only and is not investment advice.